Cipan

Cipan (Companhia Industrial Produtora de Antibióticos) is a prominent Portuguese pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), with a primary focus on antibiotics. Established in 1960, the company operates as a Contract Development and Manufacturing Organization (CDMO) providing specialized services in fermentation and chemical synthesis. Cipan is recognized as a global leader in the production of tetracycline derivatives and other complex small molecules, maintaining high-quality standards with facilities regularly inspected by the FDA and EMA. Since 2016, it has been a key part of the Suanfarma Group, which was later backed by Bain Capital, significantly enhancing its international reach and manufacturing capacity. The company serves a global clientele, providing essential ingredients for the treatment of infectious diseases.